Nan Shan Life Insurance’s CyrusOne Inc Common Stock CONE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$4.49M | – | 105 |
|
|
2021
Q4 | $4.49M | Hold |
50,000
| – | – | 0.07% | 93 |
|
|
2021
Q3 | $3.87M | Hold |
50,000
| – | – | 0.06% | 95 |
|
|
2021
Q2 | $3.58M | Hold |
50,000
| – | – | 0.06% | 100 |
|
|
2021
Q1 | $3.39M | Hold |
50,000
| – | – | 0.07% | 113 |
|
|
2020
Q4 | $3.66M | Hold |
50,000
| – | – | 0.08% | 113 |
|
|
2020
Q3 | $3.5M | Hold |
50,000
| – | – | 0.09% | 97 |
|
|
2020
Q2 | $3.64M | Hold |
50,000
| – | – | 0.11% | 90 |
|
|
2020
Q1 | $3.09M | Sell |
50,000
-75,928
| -60% | -$4.64M | 0.11% | 81 |
|
|
2019
Q4 | $8.24M | Sell |
125,928
-1,055,557
| -89% | -$72.5M | 0.26% | 61 |
|
|
2019
Q3 | $93.5M | Sell |
1,181,485
-646,877
| -35% | -$43.2M | 2.57% | 10 |
|
|
2019
Q2 | $106M | Sell |
1,828,362
-289,896
| -14% | -$17M | 2.7% | 8 |
|
|
2019
Q1 | $111M | Sell |
2,118,258
-113,235
| -5% | -$5.92M | 2.19% | 15 |
|
|
2018
Q4 | $118M | Buy |
2,231,493
+624,159
| +39% | +$35.7M | 2.82% | 8 |
|
|
2018
Q3 | $102M | Buy |
1,607,334
+548,138
| +52% | +$35.5M | 1.98% | 15 |
|
|
2018
Q2 | $61.8M | Buy |
1,059,196
+86,685
| +9% | +$4.7M | 1.43% | 21 |
|
|
2018
Q1 | $49.8M | Buy |
972,511
+194,534
| +25% | +$10.4M | 1.02% | 28 |
|
|
2017
Q4 | $46.3M | Buy |
+777,977
| New | +$47.2M | 1.2% | 26 |
|
Other funds holding CONE
Nan Shan Life Insurance's CONE Position: Q1 2022 in Review
Nan Shan Life Insurance sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 50,000 shares — an estimated $4.49M sold.
Nan Shan Life Insurance first reported a position in CONE in Q4 2017 and held it in 17 quarters. The position peaked at $118M in Q4 2018. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.
- Nan Shan Life Insurance reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
- Nan Shan Life Insurance sold 50,000 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $4.49M.
- Nan Shan Life Insurance first reported a position in CyrusOne Inc Common Stock in Q4 2017 and held it in 17 quarters.
- Nan Shan Life Insurance's CyrusOne Inc Common Stock position peaked at $118M in Q4 2018.
- 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.
Based on Nan Shan Life Insurance's 13F filing for Q1 2022, filed 13 May 2022.